Table 1 Patient demographics and baseline disease characteristics, safety population
G-GR 1800 mg/day | |
|---|---|
(n = 556) | |
Age (years) | |
Mean (SD) | 66.7 (12.9) |
Median | 69.0 |
Range | 18–92 |
Age category, n (%) | |
< 55 years | 89 (16.0) |
55–64 years | 109 (19.6) |
65–74 years | 195 (35.1) |
≥ 75 years | 163 (29.3) |
Sex, n (%) | |
Male | 221 (39.7) |
Female | 335 (60.3) |
Race, n (%) | |
Caucasian | 479 (86.2) |
African American | 29 (5.2) |
Hispanic | 38 (6.8) |
Other | 10 (1.8) |
Baseline VAS (mm) | |
Mean (SD) | 66.1 (56.9) |
Median | 64.0 |
Range | 2–91 |
Baseline VAS category, n (%) | |
≤ 20 mm | 15 (2.7) |
> 20 mm | 531 (95.5) |
Baseline BPI Sleep Interference by Pain | |
Mean (SD) | 5.1 (2.9) |
Median | 5 |
Range | 0–10 |